NYSE:BSXBoston Scientific Stock Price, Forecast & News

Boston Scientific's stock was trading at $33.86 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BSX shares have increased by 15.7% and is now trading at $39.16.
View which stocks have been most impacted by COVID-19.

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last year. There are currently 2 hold ratings, 19 buy ratings and 3 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Boston Scientific.

Boston Scientific is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Boston Scientific.

Boston Scientific Co. (NYSE:BSX) issued its quarterly earnings data on Wednesday, July, 29th. The medical equipment provider reported $0.08 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.12. The medical equipment provider had revenue of $2 billion for the quarter, compared to the consensus estimate of $1.68 billion. Boston Scientific had a return on equity of 12.86% and a net margin of 39.18%. The company's revenue for the quarter was down 23.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.39 earnings per share.
View Boston Scientific's earnings history.

24 equities research analysts have issued 12-month price objectives for Boston Scientific's shares. Their forecasts range from $25.00 to $58.00. On average, they expect Boston Scientific's stock price to reach $45.00 in the next year. This suggests a possible upside of 14.9% from the stock's current price.
View analysts' price targets for Boston Scientific.

Media coverage about BSX stock has trended somewhat negative on Friday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Boston Scientific earned a coverage optimism score of -1.3 on InfoTrie's scale. They also assigned news stories about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days.
View the latest news about Boston Scientific.

Boston Scientific saw a increase in short interest in May. As of May 29th, there was short interest totaling 17,060,000 shares, an increase of 52.3% from the May 14th total of 11,200,000 shares. Based on an average daily volume of 12,480,000 shares, the short-interest ratio is presently 1.4 days.
View Boston Scientific's Short Interest.

Some companies that are related to Boston Scientific include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Stryker (SYK), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Hologic (HOLX), Varian Medical Systems (VAR), Steris (STE) and ABIOMED (ABMD).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA), Alibaba Group (BABA), salesforce.com (CRM), Bank of America (BAC), Walt Disney (DIS), Cisco Systems (CSCO), AT&T (T), Paypal (PYPL), CVS Health (CVS) and Intel (INTC).

Boston Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "BSX."

Boston Scientific's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (7.91%), Viking Global Investors LP (1.32%), Newport Trust Co (0.63%), Swiss National Bank (0.41%), Sumitomo Mitsui Trust Holdings Inc. (0.40%) and Marshall Wace North America L.P. (0.37%). Company insiders that own Boston Scientific stock include Arthur C Butcher, Daniel J Brennan, David A Pierce, Desiree Ralls-Morrison, Edward F Mackey, Eric Francis Yves Thepaut, Halliday Hamish, Jeffrey B Mirviss, Jodi Euerle Eddy, John Bradley Sorenson, John E Sununu, Joseph Michael Fitzgerald, Kevin J Ballinger, Maulik Nanavaty, Michael F Mahoney, Wendy Carruthers, Williamson Scott, Xin Warren Wang and Yoshiaki Fujimori.
View institutional ownership trends for Boston Scientific.

BSX stock was sold by a variety of institutional investors in the last quarter, including Viking Global Investors LP, Senator Investment Group LP, Toronto Dominion Bank, Sumitomo Mitsui Trust Holdings Inc., Strs Ohio, Atalanta Sosnoff Capital LLC, Diamond Hill Capital Management Inc., and California Public Employees Retirement System. Company insiders that have sold Boston Scientific company stock in the last year include Arthur C Butcher, Daniel J Brennan, David A Pierce, Desiree Ralls-Morrison, Eric Francis Yves Thepaut, Jeffrey B Mirviss, John Bradley Sorenson, Joseph Michael Fitzgerald, Maulik Nanavaty, and Wendy Carruthers.
View insider buying and selling activity for Boston Scientific.

BSX stock was bought by a variety of institutional investors in the last quarter, including Winslow Capital Management LLC, Vanguard Group Inc., Locust Wood Capital Advisers LLC, SeaTown Holdings Pte. Ltd., FIL Ltd, State of Tennessee Treasury Department, Tocqueville Asset Management L.P., and Fisher Asset Management LLC. Company insiders that have bought Boston Scientific stock in the last two years include John E Sununu, and Williamson Scott.
View insider buying and selling activity for Boston Scientific.

Shares of BSX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BSX stock can currently be purchased for approximately $39.16.

Boston Scientific has a market capitalization of $56.03 billion and generates $10.74 billion in revenue each year. The medical equipment provider earns $4.70 billion in net income (profit) each year or $1.58 on an earnings per share basis. Boston Scientific employs 36,000 workers across the globe.

The official website for Boston Scientific is www.bostonscientific.com.

Boston Scientific's mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The medical equipment provider can be reached via phone at 508-683-4000 or via email at [email protected]